glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with calpain in 1 studies
| Studies (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Trials (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Studies (calpain) | Trials (calpain) | Recent Studies (post-2010) (calpain) |
|---|---|---|---|---|---|
| 162 | 1 | 20 | 7,019 | 25 | 2,422 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byzova, TV; Plow, EF | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and calpain
| Article | Year |
|---|---|
Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin.
Topics: Adenosine Diphosphate; Aorta; Calpain; Cytochalasin B; Endothelium, Vascular; Fibrinogen; Hemostasis; Homeostasis; Humans; Manganese; Oligopeptides; Protein Kinase C; Prothrombin; Receptors, Vitronectin; Signal Transduction; Tetradecanoylphorbol Acetate | 1998 |